Guo, Shan-Shan <br/><br/>
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy.  [electronic resource] 

 -  BMC cancer  Dec 2015 
 - 977 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-015-1964-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma<br/>Chemoradiotherapy--methods<br/>Cisplatin--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Nasopharyngeal Carcinoma<br/>Nasopharyngeal Neoplasms--drug therapy<br/>Proportional Hazards Models<br/>Radiotherapy, Intensity-Modulated<br/>Retrospective Studies<br/>Treatment Outcome